Epidemiology of Plasmodium vivax Malaria in India

被引:69
作者
Anvikar, Anupkumar R. [1 ]
Shah, Naman [1 ]
Dhariwal, Akshay C. [2 ]
Sonal, Gagan Singh [2 ]
Pradhan, Madan Mohan [3 ]
Ghosh, Susanta K. [4 ]
Valecha, Neena [1 ]
机构
[1] Indian Council Med Res, Natl Inst Malaria Res, Sect 8, New Delhi 110077, India
[2] Natl Vector Borne Dis Control Programme, Delhi, India
[3] Natl Vector Borne Dis Control Programme, Bhubaneswar, Orissa, India
[4] Natl Inst Malaria Res, Field Unit, Bangalore, Karnataka, India
关键词
SENTINEL SITES OUTCOMES; RISK-FACTORS; TREATMENT FAILURE; DRUG-RESISTANCE; PRIMAQUINE; EFFICACY; RELAPSES; ORISSA; CHLOROQUINE; POPULATION;
D O I
10.4269/ajtmh.16-0163
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Historically, malaria in India was predominantly caused by Plasmodium vivax, accounting for 53% of the estimated cases. After the spread of drug-resistant Plasmodium falciparum in the 1990s, the prevalence of the two species remained equivalent at the national level for a decade. By 2014, the proportion of P.vivax has decreased to 34% nationally, but with high regional variation. In 2014, P.vivax accounted for around 380,000 malaria cases in India; almost a sixth of all P.vivax cases reported globally. Plasmodium vivax has remained resistant to control measures, particularly in urban areas. Urban malaria is predominantly caused by P.vivax and is subject to outbreaks, often associated with increased mortality, and triggered by bursts of migration and construction. The epidemiology of P.vivax varies substantially within India, including multiple relapse phenotypes with varying latencies between primary infection and relapse. Moreover, the hypnozoite reservoir maintains transmission potential and enables reestablishment of the parasite in areas in which it was thought eradicated. The burden of malaria in India is complex because of the highly variable malaria eco-epidemiological profiles, transmission factors, and the presence of multiple Plasmodium species and Anopheles vectors. This review of P.vivax malaria in India describes epidemiological trends with particular attention to four states: Gujarat, Karnataka, Haryana, and Odisha.
引用
收藏
页码:108 / 120
页数:13
相关论文
共 56 条
  • [1] Acharya A. R., 2013, Archives of Applied Science Research, V5, P104
  • [2] Studies on the Plasmodium vivax relapse pattern in Delhi, India
    Adak, T
    Sharma, VP
    Orlov, VS
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 59 (01) : 175 - 179
  • [3] Plasmodium vivax polymorphism in a clinical drug trial
    Adak, T
    Valecha, N
    Sharma, VP
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) : 891 - 894
  • [4] Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency
    Baird, J. Kevin
    [J]. BMC MEDICINE, 2015, 13
  • [5] Balgir RS., 2010, INDIA J COMMUNITY GE, V1, P117, DOI [10.1007/s12687-010-0016-y, DOI 10.1007/S12687-010-0016-Y]
  • [6] Barua Nupur, 2011, Indian J Public Health, V55, P107, DOI 10.4103/0019-557X.85242
  • [7] Basnyat B, 2011, LANCET, V377, P993, DOI 10.1016/S0140-6736(11)60381-4
  • [8] Bhasin M. K., 2006, International Journal of Human Genetics, V6, P49
  • [9] Role of Serum Lactate and Malarial Retinopathy in Prognosis and Outcome of Falciparum and Vivax Cerebral Malaria: A Prospective Cohort Study in Adult Assamese Tribes
    Chaudhari, Kaustubh Suresh
    Uttarwar, Sahil Prashant
    Tambe, Nikhil Narayan
    Sharma, Rohan S.
    Takalkar, Anant Arunrao
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2016, 8 (02) : 61 - 67
  • [10] State of the Globe: The Resurgence of Vivax
    Chauhan, Vivek
    Raina, Sunil Kumar
    Thakur, Suman
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2016, 8 (02) : 59 - +